Front Month Nymex Natural Gas Rose 6.73% This Week to Settle at $2.9020 — Data Talk
Front Month Nymex Natural Gas for Nov. (new front month) delivery gained 18.30 cents per million British thermal units, or 6.73% to $2.9020 per million British thermal units this week
--Largest one week gain since the week ending June 7, 2024
--Largest one week percentage gain since the week ending Sept. 6, 2024
--Up for four consecutive weeks
--Today it is up 14.90 cents or 5.41%
--Largest one day dollar and percentage gain since Monday, Sept. 23, 2024
--Up five of the past seven sessions
--Highest settlement value since Tuesday, June 18, 2024
--Off 18.83% from its 52-week high of $3.575 hit Tuesday, Oct. 31, 2023
--Up 84.25% from its 52-week low of $1.575 hit Tuesday, March 26, 2024
--Down 0.92% from 52 weeks ago
--Off 12.41% from its 2024 settlement high of $3.313 hit Friday, Jan. 12, 2024
--Up 84.25% from its 2024 settlement low of $1.575 hit Tuesday, March 26, 2024
--Off 81.13% from its record high of $15.378 hit Tuesday, Dec. 13, 2005
--Month-to-date it is up 36.44%
--Year-to-date it is up 38.80 cents or 15.43%
All prices are calculated based on the settlement price of the current front month contract.
Source: Dow Jones Market Data
(END) Dow Jones Newswires
September 27, 2024 15:00 ET (19:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks